What sector does Fate Therapeutics, Inc (FATE) operate in?
Fate Therapeutics, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Fate Therapeutics, Inc (FATE) current stock price?
As of the latest data, Fate Therapeutics, Inc stock price is $2.75, with a previous close of $2.83. Fate Therapeutics, Inc lost -$0.08 in the last trading session, representing a -2.83% loss.
What is Fate Therapeutics, Inc (FATE) current market capitalization?
Fate Therapeutics, Inc market cap is approximately 320.54 million.
What is Fate Therapeutics, Inc (FATE) Earnings Per Share (EPS)?
The trailing EPS is -$1.09, and the forward EPS is -$0.99.
What is Fate Therapeutics, Inc (FATE) EBITDA?
Fate Therapeutics, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -28.30 million.
Does Fate Therapeutics, Inc (FATE) pay dividends?
No. Fate Therapeutics, Inc does not pay a dividend.
How did Fate Therapeutics, Inc (FATE) perform in its most recent earnings report?
In the last report (March 31, 2026), Fate Therapeutics, Inc posted an EPS surprise of 7.14% and a revenue surprise of -15.96%.
When is Fate Therapeutics, Inc (FATE) next earnings report?
Fate Therapeutics, Inc is expected to release its next earnings report on June 30, 2026.
What is Fate Therapeutics, Inc (FATE) beta (volatility) score?
Fate Therapeutics, Inc has a beta of 2.520, indicating very high volatility compared to the market.